A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on Famitinib

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

August 13, 2020

Study Completion Date

August 31, 2020

Conditions

Healthy Adult Subjects

Interventions

DRUG

Famitinib capsule

single dose and co-administrated with Rifampicin capsule

DRUG

Rifampicin capsule

repeated doses of Rifampicin capsule

Trial Locations (1)

Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04494659 - A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on Famitinib | Biotech Hunter | Biotech Hunter